News
In Abrupt Reversal, FDA Suspends Ixchiq Vaccine Over Safety Concern
According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events that happened outside the U.S., three of which were in people ages 70 to 82 years and the other in a 55-year-old individual.
FDA suspends license for chikungunya vaccine Ixchiq over serious safety concerns
The US Food and Drug Administration (FDA) announced late last week that it has suspended the license for French drugmaker Valneva's chikungunya vaccine, saying that continued administration of the vaccine to the public would pose a danger to health.
Valneva Shares Tumble After Chikungunya Vaccine License Suspended in U.S.
Valneva shares dropped after it said it will no longer be able to sell its chikungunya vaccine in the U.S. after reports linked the vaccine to adverse effects. Shares trading in New York were nearly 22% lower ahead of the morning bell at $9.
An influential vaccine panel’s task force will be led by a member who has previously expressed distrust in the Covid vaccine, ...
The Trump administration will move to pull the COVID vaccine off the U.S. market “within months,” one of Robert F. Kennedy Jr ...
The U.S. Centers for Disease Control and Prevention has chosen Retsef Levi, a member of its key vaccine panel, to lead its ...
Those with private health insurance expected to have an easier time getting vaccines than those on Medi-Cal if CDC changes ...
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone CAMBRIDGE, MA / ACCESS ...
FILE PHOTO: Professor of Operations Management, Retsef Levi, MD, speaks as members of the Advisory Committee on Immunization ...
The American Academy of Pediatrics and CDC have shared different recommendations for children getting COVID-19 vaccines. Here ...
By Apurva Mahajan, MediaNews Group The number of Michigan students with vaccine waivers has nearly doubled since the ...
Fox News senior medical analyst Dr. Marc Siegel weighs in on Health and Human Services Secretary Robert F. Kennedy Jr.
The U.S. Centers for Disease Control and Prevention has chosen Retsef Levi, a member of its key vaccine panel, to lead its ...
As nonmedical exemptions rise across the country, vaccine rates among kindergarteners are steadily decreasing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback